ChrysCapital
No summary available yet.
ChrysCapital is the greybeard of Indian PE - been around since 1999 and survived every cycle, which counts for something. They successfully managed founder transition away from Ashish Dhawan, no easy feat in founder-driven firms. Portfolio companies praise their "proactive and responsive mindset," deep financial services understanding, and "quick response time." Their senior team averages 20+ years at the firm - that's institutional memory you can't buy. But here's the thing: they're big, established, and institutional. Just raised a record $2.2 billion Fund X - that's serious money that needs serious returns. If you're a scrappy startup looking for hands-on guidance and patient capital, this might feel more like partnering with a bank than a VC.
- —Best for: Scale-ready companies in financial services, healthcare, or consumer with proven business models
- —Watch out for: Big fund, big expectations - they need massive exits to move the needle
- —Known for: Deep sector expertise, institutional approach, and strong India track record across cycles
ChrysCapital finds best-in-class companies in high-growth, high-ROCE sectors that are open to working with investors as agents of change. They combine this investment philosophy with deep expertise in their focus sectors to drive consistent performance across economic and political cycles. Their contrarian approach believes "Today's fallen stars can become tomorrow's angels."
ChrysCapital makes minority growth and control investments across Business Services, Financial Services, Pharma, Consumer, New Economy, Healthcare Services, and Manufacturing sectors. Founded in 1999, they've raised $5 billion across 9 private equity funds and invested $4 billion across almost 100 deals with $6.5 billion realized from 75+ exits at 2.6x ROI.
Managing Partner since 1999, he previously worked at Chilton Investment Company covering technology stocks and Goldman Sachs in principal investment area in New York. He holds a BS in computer science with magna cum laude honours from Cornell University.
Vice Chairperson of IVCA and Partner & COO at ChrysCapital, recently awarded Changemaker of the Year Award - Private Equity for making DEI a core facet of ChrysCapital culture. Among the very first hires at the firm.
Been with ChrysCapital since 2004, has 27 years of management experience in pharmaceuticals, including two decades at Ranbaxy as country head for China, regional director for India and the Middle East, and VP of corporate affairs.
Joined in July 2022 as Operating Partner for IT and Business Services, previously CEO and MD of Larsen & Toubro Infotech during 2015-2022 high-growth period. Under his leadership, LTI crossed $2bn revenue and market cap grew 10x.
Have a specific question about ChrysCapital?
Ask Bernie →